Taiwan FDA conducts on-site audit of QSD application for specific high risk devices with product scopes: Replacement heart valve, Vascular graft prosthesis, Keratoprosthesis, Passive tendon prosthesis, etc.
We use cookies to improve our site and to analyze traffic. By clicking “agree”to continuing to use this site or closing this website.
We don't support this version of your browser.